103 results
8-K
APLS
Apellis Pharmaceuticals Inc
14 May 24
Entry into a Material Definitive Agreement
8:09am
additional $100 million draw at the Company’s option upon satisfaction of a $50 million minimum cash requirement and a requirement that the Company’s
S-8
EX-5.1
APLS
Apellis Pharmaceuticals Inc
27 Feb 24
Registration of securities for employees
7:35am
the Certificate of Incorporation and Bylaws of the Company, each as amended and restated to date, and originals, or copies certified to our satisfaction, of all
8-K
EX-1.1
9p0plywi4 gimv
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
424B5
qzwef4es2
1 Nov 23
Prospectus supplement for primary offering
7:51am
8-K
EX-10.1
cb7em65sbf
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
pkuhcybth nd4
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-99.1
nixj8brikfmx6mtxc
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
re0mva
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
EX-10.1
bp7w6gxofutr
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
j1a7iug2pt 1u2eq
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm